Your browser doesn't support javascript.
loading
An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022.
Hassanein, Mohamed; Binte Zainudin, Sueziani; Shaikh, Shehla; Shaltout, Inass; Malek, Rachid; Buyukbese, Mehmet Akif; Alfadhli, Eman M; Shaikh, Khalid; Hussein, Zanariah; Eliana, Fatimah; Hafidh, Khadija; El Toony, Lobna F; Fariduddin, Mohammed; Alabbood, Majid; Batais, Mohammed Ali; Akter, Nazma; Rosandi, Rulli; Odhaib, Samih Abed; Al Amoudi, Reem; Ahmedani, Muhammad Yakoob.
Afiliação
  • Hassanein M; Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates.
  • Binte Zainudin S; Sengkang General Hospital, Sengkang, Singapore.
  • Shaikh S; KGN Diabetes and Endocrinology Center, Mumbai, India.
  • Shaltout I; Arabic Association for the Study of Diabetes and Metabolism, Cairo, Egypt.
  • Malek R; Department of Internal Medicine, CHU, Setif, Algeria.
  • Buyukbese MA; Medistate Kavacik Hospital, Istanbul, Turkey.
  • Alfadhli EM; King Faisal Specialist Hospital and Research Center, Taibah University, Madinah, Saudi Arabia.
  • Shaikh K; Royal Oman Police Hospital, Muscat, Oman.
  • Hussein Z; Putrajaya Hospital, Putrajaya, Malaysia.
  • Eliana F; Yarsi University, Jakarta, Indonesia.
  • Hafidh K; Dubai Academic Health Corporation, Dubai, United Arab Emirates.
  • El Toony LF; Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Fariduddin M; Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Alabbood M; University of Basrah, Basra, Iraq.
  • Batais MA; King Khalid University Hospital, Riyadh, Saudi Arabia.
  • Akter N; Marks Medical College and Hospital, Dhaka, Bangladesh.
  • Rosandi R; Brawijaya University, Malang, Indonesia.
  • Odhaib SA; Thi Qar Specialized Diabetes Endocrine and Metabolism Center, Thi Qar Health Directorate, Thi Qar, Iraq.
  • Al Amoudi R; Department of Medicine, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Research Center, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
  • Ahmedani MY; Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi, Pakistan.
Curr Med Res Opin ; 40(9): 1515-1523, 2024 Sep.
Article em En | MEDLINE | ID: mdl-39076065
ABSTRACT

BACKGROUND:

Managing diabetes during Ramadan fasting is a challenge due lifestyle changes. We described the characteristics and patterns of care for type 2 diabetes mellitus (T2DM) during Ramadan 2020 and 2022.

METHODS:

Our study included multinational Muslims with T2DM who were during routine consultation. We collected data on demographics, fasting characteristics, and complications. Descriptive statistics, chi-square test, and multiple testing were performed.

RESULTS:

12,529 patients participated. Mean age was 55.2 ± 11.8 years; 52.4% were females. Mean diabetes duration was 9.9 ± 7.4 years; 27.7% were with HbA1c >9% (75 mmol/mol) and 70% had complications. Metformin was the most used medication followed by insulin. 85.1% fasted ≥1 day; fasting mean duration was 27.6 ± 5.6 days. Hypoglycemia occurred in 15.5% of whom 11.7% attended emergency department or were hospitalized; this was significantly associated with age and/or duration of diabetes. Hyperglycemia occurred in 14.9% of whom 6.1% attended emergency department or were hospitalized and was also associated with age or duration of diabetes. 74.2% performed SMBG during fasting. 59.2% were educated on Ramadan fasting, with 89.7% receiving it during routine consultation.

CONCLUSIONS:

Ramadan fasting in T2DM is high. Multidisciplinary approach is required to mitigate complications. Our findings support current recommendations for safe fasting.
The goal of this survey was to describe the characteristics and current ways of care for Muslim patients with type 2 diabetes mellitus fasting during and after Ramadan 2020 and 2022. Most of the participants fasted a minimum of one day during Ramadan (85.1%). Overall, 15.5 and 14.9% reported low blood sugar levels or high blood sugar levels during fasting, respectively. Low blood sugar level was more reported in patients with older age, patients with longer diabetes duration, and women. High blood sugar level was more reported in patients with longer diabetes duration. Educational programs focusing on the risks occurring with fasting and practices that improve control of the disease will raise knowledge and awareness among patients with diabetes. Improving blood sugar control during Ramadan fasting remains a major need for both patients and healthcare providers who should collaborate to reduce the risk of diabetes-related problems.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Jejum / Diabetes Mellitus Tipo 2 / Islamismo Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Curr Med Res Opin Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Emirados Árabes Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Jejum / Diabetes Mellitus Tipo 2 / Islamismo Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Curr Med Res Opin Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Emirados Árabes Unidos País de publicação: Reino Unido